Very Rare Cancer Consortium Tumor Board Meeting

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

WHEN:
Thursday, September 17, 2020
4pm – 6pm

ANAL CANCER & HIV

Case Conference 
This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

Anal cancer is a rare disease with limited therapeutic options. The majority of cases are caused by HPV infection. In recent years clinicians have noted an increase in anal cancer among people with HIV in the greater NYC area. Patients with HIV have a substantial risk of aggressive high-grade anal cancer precursors and may also have worse outcomes from anal cancer. This raises questions about the role of HIV in the natural history of this poorly understood cancer and possible carcinogenic and prognostic synergies in HIV and HPV co-infection. We will hear from experts from different areas in these studies and discuss potential collaborations through the VRCC.

SPEAKERS

Kevin Du, MD, PhD, MSCI Associate Professor Residency Program Director Department of Radiation Oncology NYU Langone Medical Center “Disease Overview”

Paz Polak, PhD Assistant Professor Department of Oncological Sciences Icahn School of Medicine at Mount Sinai

Keith Sigel, MD, PhD, MPH Associate Professor of Medicine Division of General Internal Medicine Division of Infectious Diseases Icahn School of Medicine at Mount Sinai “Persistent HPV16 and Multifocal Recurrent Carcinoma in Situ in a Person with HIV,  As Part of an Ethnically Diverse Cohort of Precancer Patients” (Copresented with Paz Polak, PhD)

David P. Horowitz, MD Assistant Professor of Radiation Oncology NewYork-Presbyterian/Columbia University Irving Medical Center “47-Year-Old Woman with Kidney Transplant and History of Vulvar Intraepithelial Neoplasia Who Develops Anal Cancer While On Surveillance for Gynecological Malignancy”

Michael Buckstein, MD, PhD Associate Professor and Residency Program Director Department of Radiation Oncology Icahn School of Medicine at Mount Sinai “A 41-Year-old Male with HIV, HSIL, and a Buschke-Lowenstein Tumor of the Anus”

Paul Romesser, MD Assistant Attending Early Drug Development Service, Department of Medicine Gastrointestinal Service, Department of Radiation Oncology Memorial Sloan Kettering Cancer Center

Salma Jabbour, MD Professor, Vice Chair of Clinical Research & Faculty Development Department of Radiation Oncology Rutgers Cancer Institute of New Jersey “57-Year-Old Woman with Synchronous Anal and Cervical Squamous Cell Carcinomas” “71-Year-Old Man Who Developed Lung Squamous Cell Carcinoma Years After Anal Squamous Cell Carcinoma” (Copresented with Paul Romesser, MD)

Timothy Wilkin, MD, MPH Professor of Medicine, Division of Infectious Diseases Assistant Dean, Clinical Research Compliance Institutional Official for Human Research Protections Weill Cornell Medicine/NewYork-Presbyterian “Man Living with HIV Develops Anal Cancer During Extended Observation of Anal High Grade SIL”

Any questions on this event, contact events@nygenome.org.